Jason Matuszewski, CEO of BioStem Technologies
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
February 26, 2024 10:39 ET | PRISM MarketView
PRISM MarketView Highlights BioStem Technologies as it Targets Significant Opportunity in Wound Care Markets
Biostem main logo .png
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
January 30, 2024 16:05 ET | Biostem Technologies
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
Biostem main logo .png
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
January 11, 2024 08:30 ET | Biostem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer role
Biostem main logo .png
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
December 19, 2023 08:30 ET | Biostem Technologies
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
We Manufacture Products That Change Lives
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions
December 14, 2023 08:30 ET | Biostem Technologies
The Center for Medicare Services (CMS) has established national pricing for AmnioWrap2(TM) in all Medicare Administrative Contractors (MAC) regions
BioStem Technologies Main Logo.jpg
BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.
July 23, 2021 09:00 ET | BioStem Technologies, Inc.
Pompano Beach, Fl., July 23, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies Main Logo.jpg
BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion
April 15, 2021 09:00 ET | BioStem Technologies, Inc.
Pompano Beach, Fl., April 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies Main Logo.jpg
BioStem Technologies, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2020
April 05, 2021 09:00 ET | BioStem Technologies, Inc.
Pompano Beach, Fl., April 05, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...
BioStem Technologies Main Logo.jpg
BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™
March 25, 2021 09:00 ET | BioStem Technologies, Inc.
Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies Main Logo.jpg
BioStem Technologies Engages D. Brooks & Associates for 2020 and 2019 Audit
March 15, 2021 09:00 ET | BioStem Technologies, Inc.
Pompano Beach, Fl., March 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...